Mark Ide

Prof. Mark Ide

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MIMark Ide
Mark Ide
MHMarina Harris
Marina Harris
ASAnnette Stevens
Annette Stevens
RSRebecca Sussams
Rebecca Sussams
VHViv Hopkins
Viv Hopkins
CHClive Holmes
Clive Holmes
Periodontitis is common in the elderly and may become more common in Alzheimer’s disease because of a reduced ability to take care of oral hygiene as the disease progresses. Elevated antibodies to periodontal bacteria are associated with an increased systemic pro-inflammatory state. Elsewhere raised serum pro-inflammatory cytokines have been associated with an increased rate of cognitive decline in Alzheimer’s disease. We hypothesized that periodontitis would be associated with increased dementia severity and a more rapid cognitive decline in Alzheimer’s disease. We aimed to determine if periodontitis in Alzheimer’s disease is associated with both increased dementia severity and cognitive decline, and an increased systemic pro inflammatory state. In a six month observational cohort study 60 community dwelling participants with mild to moderate Alzheimer’s Disease were cognitively assessed and a blood sample taken for systemic inflammatory markers. Dental health was assessed by a dental hygienist, blind to cognitive outcomes. All assessments were repeated at six months. The presence of periodontitis at baseline was not related to baseline cognitive state but was associated with a six fold increase in the rate of cognitive decline as assessed by the ADAS-cog over a six month follow up period. Periodontitis at baseline was associated with a relative increase in the pro-inflammatory state over the six month follow up period. Our data showed that periodontitis is associated with an increase in cognitive decline in Alzheimer’s Disease, independent to baseline cognitive state, which may be mediated through effects on systemic inflammation.

11 September 2004 in British Dental Journal
Verified
Journal Article
Closed access
SMS Moore
S Moore
MIMark Ide
Mark Ide
PCP Y Coward
P Y Coward
MRM Randhawa
M Randhawa
EBE Borkowska
E Borkowska
RWR F Wilson
R F Wilson

14 April 2003 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
MIMark Ide
Mark Ide
DMD. McPartlin
D. McPartlin
PCP.Y. Coward
P.Y. Coward
MCM. Crook
M. Crook
PLP. Lumb
P. Lumb
RWR.F. Wilson
R.F. Wilson

18 April 2007
Verified
Reference Entry
Closed access
PDF file
ARAnna Renz
Anna Renz
MIMark Ide
Mark Ide
JNJonathon Timothy Newton
Jonathon Timothy Newton
PRPeter Robinson
Peter Robinson
DSDebbie Smith
Debbie Smith

1 March 2004 in Journal of Periodontology
Verified
Journal Article
Closed access
MIMark Ide
Mark Ide
DJDaljit Jagdev
Daljit Jagdev
PCPaula Y. Coward
Paula Y. Coward
MCMartin Crook
Martin Crook
GBG. Robin Barclay
G. Robin Barclay
RWRon F. Wilson
Ron F. Wilson
Background: The acute‐phase response involves molecules including tumor necrosis factor‐alpha (TNF‐α), interleukin‐6 (IL‐6), and C‐reactive protein (CRP). This study aimed to determine whether subgingival scaling resulted in rapid changes in plasma concentrations of these molecules.Methods: Twenty‐three non‐smoking adults with chronic periodontitis received subgingival scaling for 60 minutes. Venous blood samples were taken at 0, 15, 30, 60, and 120 minutes. TNF‐ α and IL‐6 were assayed from all samples and CRP from the baseline and final samples. Lipopolysaccharide (LPS) was assayed at 0, 15, and 30 minutes using limulus lysate assay (LAL) and EndoCAb Ig assays.Results: LPS assays were suggestive of a transient low‐grade bacteremia, but changes in LPS approaching significance (P = 0.061) were seen with LAL only. There was a significant increase in circulating TNF‐α (P = 0.0387) and IL‐6 (P <0.0001), and the degree of change in TNF‐α was correlated with the severity of periodontal breakdown (P = 0.001). There was also a significant correlation between levels of IL‐6 and TNF‐α (P <0.001).Conclusions: Chronic periodontitis patients undergoing an episode of subgingival scaling show a significant elevation in circulating TNF‐α and IL‐6. This may account for anecdotal reports of pyrexia following treatment and may be significant in terms of the relationship between periodontal disease, bacteremia, and cardiovascular disease. J Periodontol 2004;75:420‐428.

1 March 2021 in Journal of Dentistry
Verified
Journal Article
Open access
NWNicola West
Nicola West
ICIain L.C. Chapple
Iain L.C. Chapple
NCNick Claydon
Nick Claydon
FDFrancesco D'Aiuto
Francesco D'Aiuto
NDNikolaos Donos
Nikolaos Donos
MKMoritz Kebschull
Moritz Kebschull
To adapt the supranational European Federation for Periodontology (EFP) S3-Level Clinical Practice Guideline for treatment of periodontitis (stage I-III) to a UK healthcare environment, taking into account the views of a broad range of stakeholders, and patients. This UK version is based on the supranational EFP guideline (Sanz et al., 2020) published in the Journal of Clinical Periodontology. The source guideline was developed using the S3-level methodology, which combined the assessment of formal evidence from 15 systematic reviews with a moderated consensus process of a representative group of stakeholders, and accounts for health equality, environmental factors and clinical effectiveness. It encompasses 62 clinical recommendations for the treatment of stage I-III periodontitis, based on a step-wise process mapped to the 2017 classification system. The UK version was developed from the source guideline using a formal process called the GRADE ADOLOPMENT framework. This framework allows for the adoption (unmodified acceptance), adaptation (acceptance with modifications) and the de novo development of clinical recommendations. Using this framework and following the S3-process, the underlying systematic reviews were updated and a representative guideline group of 75 delegates from 17 stakeholder organisations was assembled into three working groups. Following the formal S3-process, all clinical recommendations were formally assessed for their applicability to the UK and adoloped accordingly. Using the ADOLOPMENT protocol, a UK version of the EFP S3-level clinical practice guideline was developed. This guideline delivers evidence- and consensus-based clinical recommendations of direct relevance to the dental community in the UK. The aim of S3-level guidelines is to combine the evaluation of formal evidence, grading and synthesis with the clinical expertise of a broad range of stakeholders to form clinical recommendations. Herein, the first major international S3-level guideline in dentistry, the EFP guideline, was implemented for direct clinical applicability in the UK healthcare system.